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Background:	Reproductive	 research	 is	quintessential	 in	understanding	not	only	 the	
cause	of	infertility,	but	also	for	creating	family	planning	tools.	The	knockout	(KO)	sys-
tem	approach	is	conducive	to	discovering	genes	that	are	essential	for	fertility	in	mice.	
























contraception,	 especially	 for	men,	 is	 detrimental	 to	 society,	 for	 the	
burden	of	contraception	becomes	heavily	weighted	on	women.
The	CRISPR/Cas9	system	has	radically	transformed	the	reproduc-
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methods	have	been	established	 to	 analyze	 the	phenotypes	 in	mice,	
such	 as	 in	vitro	 fertilization,	 intracytoplasmic	 sperm	 injection,	 semi-
niferous	 tubule	 transplantation,	 and	embryo	 transfer.	 In	 this	 review,	
the	mechanisms	behind	the	CRISPR/Cas9	system	and	how	it	has	been	
applied	to	investigating	male	fertility	in	mice	will	be	discussed.
2  | ANALYSIS OF ESSENTIAL GENES 
FOR MALE FERTILITY BY USING THE 
CONVENTIONAL KNOCKOUT APPROACH
Gene	disruption	has	been	pivotal	 in	 studying	gene	 function	 in	vivo.	




cells	 (Figure	1A).	 These	pluripotent	 ES	 cells	 are	 genetically	manipu-
lated	in	a	culture4	and	then	the	surviving	cells	that	undergo	intended	








were	 later	 found	 to	 be	 dispensable	 after	 in	 vivo	 KO	 studies.5	 For	 
example,	the	protease	enzyme,	acrosin,	was	thought	to	be	necessary	
for	 zona	 pellucida	 (ZP)	 penetration,	 but	 spermatozoa	 that	 lack	 the	
active	protease	were	still	able	to	penetrate	the	ZP	and	the	KO	mice	
were	 fertile.6	 Postacrosomal	 WW	 domain-	binding	 protein	 (PAWP)	
was	thought	to	be	necessary	for	the	resumption	of	meiosis	and	pro-
nuclear	 development	 during	 egg	 activation,7	 as	 the	 sperm-	borne	
oocyte-	activating	 factor,8,9	 but	 through	 conventional	 KO	 analysis,	
PAWP	was	found	to	have	no	effect	on	the	development	of	embryos	
nor	was	any	difference	found	in	the	calcium	oscillations	that	are	nec-


















plate.14	 Similar	 to	 the	 chromosomal	 crossover	 event	 during	meiosis,	





clease	 (ZFN)	 and	 the	 transcription	 activator-	like	 effector	 nuclease	
(TALEN);	 and	 (ii)	 RNA-	inducible	 nucleases,	 such	 as	 the	 clustered,	
regularly	 interspaced,	 short	 palindromic	 repeats	 (CRISPR)/CRISPR-	
associated	9	 (Cas9)	 system.15	The	ZFNs	and	TALENs	are	 composed	
























functionally	 identified	 until	 20	years	 later.22	 There	 are	 three	 types	
of	CRISPR	systems,	but	CRISPR	type	 II	 is	most	commonly	used	for	
genome	editing	 (Figure	2B).23	 In	 this	 type,	 the	DNA	of	an	 infecting	
bacteriophage	 is	cleaved	 into	small	pieces	and	then	 integrated	 into	
the	CRISPR	locus.	Then,	when	this	sequence	is	transcribed	to	small	
CRISPR	 RNA	 (crRNA),	 it	 forms	 a	 complex	 with	 the	 endonuclease,	
Cas9,	 assisted	 by	 transactivating	 crRNA	 (tracrRNA).	 This	 complex	




NGG	 sequence—any	 nucleotide	 (N)	 and	 two	 guanines	 (GG)—after	
about	 20	bp	 of	 non-	self	 DNA,24	 and	 the	 cleavage	 site	was	 almost	
always	 3	bp	 before	 the	 PAM	 sequence.	 After	 the	 Cas9	 complex	
cleaves	both	DNA	strands,	the	double-	stranded	breaks	are	repaired	
via	a	mechanism	that	 is	mediated	by	the	NHEJ	pathway.	However,	
often	 the	 repair	 is	 imperfect,	 leading	 to	 indels.	 This	 disruption	 can	
cause	 a	 frameshift	mutation	 and	 the	 subsequent	mistranslation	 of	
the	protein.	Researchers	then	began	to	construct	different	methods	
to	 use	 this	 unique	 system	 for	 gene	modification	 in	model	 animals,	
including	mice.
4  | GENERATION OF GENE- MODIFIED 




One	 method	 of	 CRISPR/Cas9	 introduction	 involves	 co-	injecting	
a	 single-	guide	 RNA	 (sgRNA,	 a	 chimera	 of	 crRNA	 and	 tracrRNA)	
and	 the	 messenger	 (m)RNA	 encoding	 the	 Cas9	 endonuclease	 into	
the	 cytoplasm	 of	 zygotes	 (cytoplasmic	 injection	 method	 [eg	 RNA])	
(Figure	3A).25	A	plasmid-	based	delivery	 system	also	was	developed,	
in	which	a	plasmid	vector	 (pX330	 [addgene	No.	42230])	expressing	
sgRNA	 and	 Cas9	 are	 injected	 into	 the	 pronucleus	 of	 the	 fertilized	
eggs	(pronuclear	injection	method	[eg	DNA])	(Figure	3B).26	DNA	has	

















































this	method	might	be	used	more	 commonly,	 especially	 by	using	 a	
protein–RNA	 complex	 that	 causes	 immediate	DNA	 cleavage	 after	
introduction.
4.3 | Embryonic stem cell method
In	order	to	increase	the	efficiency	of	KO	and	KI	mice	production,	a	
combination	of	 the	CRISPR/Cas9	system	and	ES	cell	gene	editing	
method	 can	be	used	 (Figure	3D).33	When	 the	pX330	plasmid	 and	
a	plasmid	 carrying	 a	drug	 resistance	gene	 cassette	 are	 simultane-
ously	 transfected	 into	ES	cells	and	subjugated	 to	 short-	term	drug	
selection,	the	Cas9	protein	cleaves	most	of	the	cells.	To	make	the	





are	possible	 if	 different	 sgRNAs	 are	 simultaneously	 introduced.	 If	











to	 generate	 chimeric	mice.	The	 chimeric	mice	 can	 be	mated	 to	 ob-
tain	F1	mice	that	have	the	desired	mutation.	 In	the	zygote	 injection	
method,	many	mice	without	the	desired	mutation	are	born.	There	 is	
much	effort	 required	to	genotype	and	store	 these	mice	for	 little	 re-



















vantages.	 It	 is	extremely	fast	 to	make	transgenic	mutant	animals	by	










to	be	 specific	 to	 the	 target	 gene,	 there	 is	 still	 a	 possibility	 that	 the	
complex	could	bind	to	and	cut	an	off-	target	area	that	is	similar	to	the	
original	 on-	target	 sequence.	Most	 sgRNAs	 carry	 ~20	bp	 before	 the	








One	way	 to	 confirm	 low	 off-	target	 sequences	 is	 through	 software,	
such	as	CRISPRdirect.45
Another	method	 to	 reduce	off-	target	 effects	 is	by	 introducing	 a	
nickase	Cas9	to	the	system.46	As	the	CRISPR/Cas9	system	can	target	
only	20	bases,	 the	specificity	of	 this	 recognition	sequence	 is	 low.	 In	
comparison,	ZFN	or	TALEN	recognize	a	target	sequence	of	~40	bases.	
Therefore,	using	a	nickase	Cas9	and	using	two	sgRNAs	might	increase	
the	 specificity	 of	 the	 recognition	 sequence.	 Furthermore,	 mutated	





5  | CRISPR/CAS9 AND REPRODUCTION
5.1 | Essential genes for male fertility that have been 
found by the CRISPR/Cas9 system
The	 introduction	 of	 the	 CRISPR/Cas9	 system	 into	 the	 genome	 
editing	world	 led	 to	 the	 rapid	 creation	 of	 KO	mice.	 For	 example,	
by	utilizing	the	CRISPR/Cas9	system	in	addition	to	other	KO	meth-






CRISPR/Cas9	system,	such	as	Ppp3r2, Ccdc63, and Cabyr.
Ppp3r2	 is	 a	 component	 of	 calcineurin,	 the	 calcium-	dependent	
phosphatase,	 and	 is	 expressed	 predominantly	 in	 the	 testis.50	 It	was	




ability.	 This	 has	 a	 profound	 implication	 for	 contraception,	 as	 calci-










sheath	 is	 a	 protein	 called	 Ca2+-	binding	 tyrosine-	phosphorylation-	
regulated	 protein	 (CABYR)	 that	 is	 phosphorylated	 during	 capac-
itation.54	 In	vitro	 research	 showed	 that	CABYR	might	 play	 a	 role	 in	









The	CRISPR/Cas9	 system	 can	 be	 used	 for	 not	 only	 generating	 KO	
mice	rapidly	but	also	for	more	complicated	gene	manipulations.	Point	









male	mice	were	fertile,	 indicating	that	 the	phosphorylation	of	 these	
two	serine	residues	is	not	essential	for	male	fertility.
Another	example	of	 inserting	a	point	mutation	 into	 the	genome	
by	 using	 the	 CRISPR/Cas9	 system	 is	 in	 the	 case	 of	 IZUMO1	 and	 
understanding	its	intracellular	domain.	IZUMO1	is	an	immunoglobulin	
8  |     ABBASI et Al.
superfamily	 protein,	 is	 found	 on	 the	 acrosomal	 membrane	 of	 the	
acrosome-	intact	spermatozoa,	and	is	essential	for	sperm–egg	fusion.61 
During	the	acrosome	reaction,	IZUMO1	diffuses	from	the	acrosomal	
membrane	 to	 the	 sperm	 surface62	 and	 the	 intracellular	 domain	 of	
IZUMO1	could	be	 involved	 in	 this	 localization	change.59	 In	order	 to	
understand	the	function	of	the	intracellular	domain,	mice	that	have	a	
point	mutation	in	this	region	were	created	by	using	the	CRISPR/Cas9	













In	 order	 to	 study	 protein	 localization	 and	 functions,	 a	 set	 of	 tags	
has	been	created.	Using	the	CRISPR/Cas9	system,	these	tags,	such	














immunoprecipitation	 analysis	 as	 well,	 but	 unfortunately,	 TCTE1	






fertile,	 as	 mentioned	 above.49	 Producing	 double-	knockout	 (DKO)	
mice	by	using	the	conventional	method	is	difficult	to	do	in	one	step	
because	 there	 is	a	very	 low	possibility	of	obtaining	 the	desired	 re-
combination	events	in	both	regions	in	one	attempt.	The	DKO	crea-
tion	 would	 require	 multiple	 cross-	breedings	 with	 no	 guarantee	 of	
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electroporation,	or	transfection,	Cas9	would	snip	those	sites,	render-
ing	both	genes	non-	functional.
An	 example	 of	 this	 mechanism	 using	 the	 CRISPR/Cas9	 system	
can	be	seen	in	research	that	was	done	on	the	Y	chromosome	genes,	
Zfy1 and Zfy2,	in	which	the	single	KO	mice	did	not	have	a	significant	 
phenotype	 but	 the	 DKO	 mice	 were	 infertile	 because	 of	 abnormal	




Before	 the	development	of	 the	CRISPR/Cas9	system,	 in	vivo	gene	
research	 was	 extremely	 tedious.	 It	 took	 years	 to	 make	 the	 same	
KO	animals	that	the	CRISPR/Cas9	system	now	produces	 in	merely	
months.	 This	 technology	 also	 has	 allowed	 researchers	 to	 perform	







mysteries	 of	 male	 fertility	 will	 be	 unraveled	 with	 the	 help	 of	 the	
CRISPR/Cas9	system.
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